Trastuzumab can increase the expression of circular RNA BGN in breast cancer cells BT474 and SKBR3, enhance the deubiquitination and expression of SLC7A11, inhibit ferroptosis, induce drug resistance in cancer tissue, an effect that can be reversed by erastin (112). Here, SLC7A11 is linked to cancer.